Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 117
2003 136
2004 157
2005 169
2006 155
2007 109
2008 115
2009 169
2010 212
2011 222
2012 214
2013 198
2014 213
2015 213
2016 273
2017 276
2018 257
2019 231
2020 258
2021 259
2022 252
2023 242
2024 245
2025 249
2026 145

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,931 results

Results by year

Filters applied: . Clear all
Page 1
In vivo chimeric antigen receptor (CAR)-T cell therapy.
Bot A, Scharenberg A, Friedman K, Guey L, Hofmeister R, Andorko JI, Klichinsky M, Neumann F, Shah JV, Swayer AJ, Trudeau K, Weissman D, Stephan MT, Buchholz CJ, June CH. Bot A, et al. Nat Rev Drug Discov. 2026 Feb;25(2):116-137. doi: 10.1038/s41573-025-01291-5. Epub 2025 Sep 30. Nat Rev Drug Discov. 2026. PMID: 41028170 Review.
Targeting immunogenic cell stress and death for cancer therapy.
Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Galluzzi L, et al. Nat Rev Drug Discov. 2024 Jun;23(6):445-460. doi: 10.1038/s41573-024-00920-9. Epub 2024 Apr 15. Nat Rev Drug Discov. 2024. PMID: 38622310 Free PMC article. Review.
New epilepsy therapies in development.
Klein P, Kaminski RM, Koepp M, Löscher W. Klein P, et al. Nat Rev Drug Discov. 2024 Sep;23(9):682-708. doi: 10.1038/s41573-024-00981-w. Epub 2024 Jul 22. Nat Rev Drug Discov. 2024. PMID: 39039153 Review.
Targeting ROS in cancer: rationale and strategies.
Glorieux C, Liu S, Trachootham D, Huang P. Glorieux C, et al. Nat Rev Drug Discov. 2024 Aug;23(8):583-606. doi: 10.1038/s41573-024-00979-4. Epub 2024 Jul 9. Nat Rev Drug Discov. 2024. PMID: 38982305 Review.
GPCR drug discovery: new agents, targets and indications.
Lorente JS, Sokolov AV, Ferguson G, Schiöth HB, Hauser AS, Gloriam DE. Lorente JS, et al. Nat Rev Drug Discov. 2025 Jun;24(6):458-479. doi: 10.1038/s41573-025-01139-y. Epub 2025 Mar 3. Nat Rev Drug Discov. 2025. PMID: 40033110 Review.
4,931 results